In-vitro activity of synercid and related drugs against Streptococcus oralis isolated from septicaemia and endocarditis cases

A. M. Rafay*

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةمراجعة النظراء

1 اقتباس (Scopus)

ملخص

Objective-The increase in resistance to gram positive organisms and seriousness of infective endocarditis, makes it necessary to look for an alternate treatment. Method-In-vitro activity of synercid was compared with penicillin, amoxycillin, teicoplanin, vancomycin, clindamycin and erythromycin. Result-Synercid showed minimum inhibitory concentrations (MIC) within the narrow range of 0.06-0.5 mg/l. MIC50 and mode values were both 0.25 mg/l. There was just two-fold difference between the MIC50 (0.25 mg/l) and the MIC90, (0.5 mg/l). Although the MICs of synercid for S. oralis were relatively high compared to penicillin, clindamycin, erythromycin and teicoplanin, the in-vitro bactericidal activity of synercid was much greater. Synercid MBC values were < 4 mg/l for most of the isolates, except for one of 16 mg/l and the other >64 mg/l. Killing curve was performed on six isolates of S. oralis from infective endocarditis, two from septicaemia patients and two from the oral flora of normal individuals. Conclusion-Synercid showed superior bactericidal activity when compared to penicillin and vancomycin against all ten isolates of S. oralis tested. Synercid was bactericidal (99.9% kill) against all ten isolates of S. oralis within six hours of contact.

اللغة الأصليةEnglish
الصفحات (من إلى)25-31
عدد الصفحات7
دوريةSultan Qaboos University Medical Journal
مستوى الصوت2
رقم الإصدار1
حالة النشرPublished - يناير 2000

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700???

بصمة

أدرس بدقة موضوعات البحث “In-vitro activity of synercid and related drugs against Streptococcus oralis isolated from septicaemia and endocarditis cases'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا